|
1
|
Hamann HA, Ver Hoeve ES, Carter-Harris L,
Studts JL and Ostroff JS: Multilevel opportunities to address lung
cancer stigma across the cancer control continuum. J Thorac Oncol.
13:1062–1075. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhuo C, Zhuang H, Gao X and Triplett PT:
Lung cancer incidence in patients with schizophrenia:
Meta-analysis. Br J Psychiatry. 215:704–711. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nooreldeen R and Bach H: Current and
Future development in lung cancer diagnosis. Int J Mol Sci.
22:86612021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen
W, Li X, Wang L, Wang L, Liu Y, et al: Mortality, morbidity, and
risk factors in China and its provinces, 1990–2017: A systematic
analysis for the Global Burden of Disease Study 2017. Lancet.
394:1145–1158. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang D, Liu Y, Bai C, Wang X and Powell
CA: Epidemiology of lung cancer and lung cancer screening programs
in China and the United States. Cancer Lett. 468:82–87. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang M, Herbst RS and Boshoff C: Toward
personalized treatment approaches for non-small-cell lung cancer.
Nat Med. 27:1345–1356. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zugazagoitia J and Paz-Ares L:
Extensive-Stage small-cell lung cancer: First-Line and second-line
treatment options. J Clin Oncol. 40:671–680. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nudel R and Newbury DF: Foxp2. Wiley
Interdiscip Rev Cogn Sci. 4:547–560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
den Hoed J, Devaraju K and Fisher SE:
Molecular networks of the FOXP2 transcription factor in the brain.
EMBO Rep. 22:e528032021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Furlong R: FOXP2 tells a cautionary tale.
Nat Rev Genet. 19:592–593. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nan CC, Zhang N, Cheung KCP, Zhang HD, Li
W, Hong CY, Chen HS, Liu XY, Li N and Cheng L: Knockdown of lncRNA
MALAT1 Alleviates LPS-Induced acute lung injury via inhibiting
apoptosis through the miR-194-5p/FOXP2 Axis. Front Cell Dev Biol.
8:5868692020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren T, Liu C, Hou J and Shan F:
Hsa_circ_0043265 suppresses proliferation, metastasis, EMT and
promotes apoptosis in non-small cell lung cancer through
miR-25-3p/FOXP2 pathway. Onco Targets Ther. 13:3867–3880. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng F, Yang X and Xiao P: DNASE1L3
regulation by transcription factor FOXP2 affects the proliferation,
migration, invasion and tube formation of lung adenocarcinoma. Exp
Ther Med. 25:722022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng D, Fu M, Wang M, Wei Y and Wei X:
Targeting TGF-β signal transduction for fibrosis and cancer
therapy. Mol Cancer. 21:1042022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hao Y, Baker D and Ten Dijke P:
TGF-beta-mediated epithelial-mesenchymal transition and cancer
metastasis. Int J Mol Sci. 20:27672019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Syed V. TGF-beta signaling in cancer. J
Cell Biochem. 117:1279–1287. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mortezaee K, Majidpoor J and Kharazinejad
E: Epithelial-mesenchymal transition in cancer stemness and
heterogeneity: Updated. Med Oncol. 39:1932022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Giannelli G, Koudelkova P, Dituri F and
Mikulits W: Role of epithelial to mesenchymal transition in
hepatocellular carcinoma. J Hepatol. 65:798–808. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou JY, Zheng SR, Liu J, Shi R, Yu HL and
Wei M: MiR-519d facilitates the progression and metastasis of
cervical cancer through direct targeting Smad7. Cancer Cell Int.
16:212016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang Y, Chen Z, Lu T, Bi G, Li M, Liang
J, Hu Z, Zheng Y, Yin J, Xi J, et al: HIF-1alpha switches the
functionality of TGF-β signaling via changing the partners of smads
to drive glucose metabolic reprogramming in non-small cell lung
cancer. J Exp Clin Cancer Res. 40:3982021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jie X, Fong WP, Zhou R, Zhao Y, Zhao Y,
Meng R, Zhang S, Dong X, Zhang T, Yang K, et al: USP9X-mediated
KDM4C deubiquitination promotes lung cancer radioresistance by
epigenetically inducing TGF-β2 transcription. Cell Death Differ.
28:2095–2111. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liao P, Huang WH, Cao L, Wang T and Chen
LM: Low expression of FOXP2 predicts poor survival and targets
caspase-1 to inhibit cell pyroptosis in colorectal cancer. J
Cancer. 13:1181–1192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Colak S and Ten Dijke P: Targeting TGF-β
signaling in cancer. Trends Cancer. 3:56–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee JH and Massague J: TGF-beta in
developmental and fibrogenic EMTs. Semin Cancer Biol. 86((Pt 2)):
136–145. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu P, Zhang X, Cao J, Yang J, Chen Z, Wang
W, Wang S, Zhang L, Xie L, Fang L, et al: The novel role of
circular RNA ST3GAL6 on blocking gastric cancer malignant
behaviours through autophagy regulated by the FOXP2/MET/mTOR axis.
Clin Transl Med. 12:e7072022. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhao Q, Liu C, Cui Q, Luan X, Wang Q and
Zhou C: miR-190b promotes colorectal cancer progression through
targeting forkhead box protein P2. Exp Ther Med. 19:79–84.
2020.PubMed/NCBI
|
|
28
|
Nong S, Wang Z, Wei Z, Ma L, Guan Y and Ni
J: HN1L promotes stem cell-like properties by regulating TGF-β
signaling pathway through targeting FOXP2 in prostate cancer. Cell
Biol Int. 46:83–95. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang R, Xiang G, Duan X, Wang H, He K and
Xiao J: MiR-132-3p inhibits proliferation, invasion and migration
of colorectal cancer cells via down-regulating FOXP2 expression.
Acta Biochim Pol. 69:371–377. 2022.PubMed/NCBI
|
|
30
|
Vernes SC, Newbury DF, Abrahams BS,
Winchester L, Nicod J, Groszer M, Alarcón M, Oliver PL, Davies KE,
Geschwind DH, et al: A functional genetic link between distinct
developmental language disorders. N Engl J Med. 359:2337–2345.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang F, Xiao Z and Zhang S: FOXP2
regulates thyroid cancer cell proliferation and apoptosis via
transcriptional activation of RPS6KA6. Exp Ther Med. 23:4342022.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tauriello DVF, Sancho E and Batlle E:
Overcoming TGFβ-mediated immune evasion in cancer. Nat Rev Cancer.
22:25–44. 2022. View Article : Google Scholar : PubMed/NCBI
|
